There's no question that many members of the panel thought that it would be advantageous to look at a system of copayments. That was really a values-based gesture, believing that everyone who can ought to contribute more directly to the cost of their care. Nevertheless, the panel hesitated to make that a clear recommendation because they were unsure of the potential consequences for low-income individuals and whether those copayments, even as low as a dollar or two, could constitute a barrier. Then you would have people not taking their medicines and being a greater cost to the system.
On December 6th, 2016. See this statement in context.